RegenETP, Inc. (RGTPQ)

Market Cap	1.12M
Revenue (ttm)	73.00K
Net Income (ttm)	-8.31M
Shares Out	7.19M
EPS (ttm)	-1.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	829
Average Volume	5,536
Open	0.1560
Previous Close	0.1700
Day's Range	0.1560 - 0.1560
52-Week Range	0.0100 - 0.2200
Beta	2.91
RSI	51.79
Earnings Date	n/a

About RegenETP

RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, o...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Richard Hague
• Employees: 43
• Stock Exchange: OTCMKTS
• Ticker Symbol: RGTPQ

Financial Performance

In 2022, RegenETP's revenue was $814,000, a decrease of -91.34% compared to the previous year's $9.40 million. Losses were -$7.83 million, -74.05% less than in 2021.